Facebook
Twitter
Telegram
Report an ErrorAnnovis Bio Balance Sheet 2011-2024 | ANVS
Annual Balance Sheet Annovis Bio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -8.07 M | - | - | - | - | - | - | - | - | - |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
4.28 M | 7.7 M | 1.51 M | 578 K | - | - | - | - | - | - | - | - | - |
Total Liabilities |
18 M | 7.7 M | 1.51 M | 578 K | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-110 M | -54.1 M | -28.7 M | -14.2 M | - | - | - | - | - | - | - | - | - |
Total Assets |
10.2 M | 36 M | 46 M | 8.12 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
5.75 M | 28.4 M | 45.7 M | 8.07 M | 1.86 K | - | - | - | - | - | - | - | - |
Book Value |
-7.75 M | 28.3 M | 44.5 M | 7.54 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-7.75 M | 28.3 M | 44.5 M | 7.54 M | -8.58 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Annovis Bio
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 606 K | 606 K | 606 K | 606 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
3.56 M | 2.07 M | 5.41 M | 7.7 M | 2.53 M | 1.3 M | 1.4 M | 1.51 M | 1.12 M | 884 K | 1.6 M | 578 K | 578 K | 578 K | 578 K | 2.62 M | 2.62 M | 2.62 M | 2.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-88 M | -73.3 M | -63.8 M | -54.1 M | -46.3 M | -39.9 M | -34 M | -28.7 M | -22.8 M | -20 M | -17.4 M | -14.2 M | -14.2 M | -14.2 M | -14.2 M | -8.78 M | -8.78 M | -8.78 M | -8.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
10.2 M | 22.8 M | 25.5 M | 36 M | 37.1 M | 40 M | 44.1 M | 46 M | 47.7 M | 49.5 M | 5.96 M | 8.12 M | 8.12 M | 8.12 M | 8.12 M | 1.12 M | 1.12 M | 1.12 M | 1.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
6.35 M | 15.7 M | 16.8 M | 28.4 M | 32 M | 36 M | 42.7 M | 45.7 M | 47.5 M | 49.2 M | 5.6 M | 8.07 M | 8.07 M | 8.07 M | 8.07 M | 1.86 K | 1.86 K | 1.86 K | 1.86 K | 35.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
6.66 M | 20.7 M | 20.1 M | 28.3 M | 34.6 M | 38.7 M | 42.7 M | 44.5 M | 46.5 M | 48.6 M | 4.37 M | 7.54 M | 7.54 M | 7.54 M | 7.54 M | -1.5 M | -1.5 M | -1.5 M | -1.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
6.66 M | 20.7 M | 20.1 M | 28.3 M | 34.6 M | 38.7 M | 42.7 M | 44.5 M | 46.5 M | 48.6 M | 4.37 M | 7.54 M | 7.54 M | 7.54 M | 7.54 M | -8.58 M | -8.58 M | -8.58 M | -8.58 M | -7.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency